These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

638 related items for PubMed ID: 11919306

  • 21. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
    Bergmann JF, Neuhart E.
    Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
    [Abstract] [Full Text] [Related]

  • 22. The post-discharge prophylactic management of the orthopedic patient with low-molecular-weight heparin: enoxaparin.
    Nilsson PE, Bergqvist D, Benoni G, Björgell O, Fredin H, Hedlund U, Nicolas S, Nylander G.
    Orthopedics; 1997 Feb; 20 Suppl():22-5. PubMed ID: 9048404
    [Abstract] [Full Text] [Related]

  • 23. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.
    Eriksson BI, Dahl OE, Rosencher N, Kurth AA, van Dijk CN, Frostick SP, Prins MH, Hettiarachchi R, Hantel S, Schnee J, Büller HR, RE-NOVATE Study Group.
    Lancet; 2007 Sep 15; 370(9591):949-56. PubMed ID: 17869635
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial.
    Haas S, Flosbach CW.
    Semin Thromb Hemost; 1993 Sep 15; 19 Suppl 1():164-73. PubMed ID: 8395721
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
    Bergqvist D.
    Br J Surg; 2004 Aug 15; 91(8):965-74. PubMed ID: 15286956
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement.
    Eriksson BI, Agnelli G, Cohen AT, Dahl OE, Mouret P, Rosencher N, Eskilson C, Nylander I, Frison L, Ogren M, METHRO III Study Group.
    Thromb Haemost; 2003 Feb 15; 89(2):288-96. PubMed ID: 12574809
    [Abstract] [Full Text] [Related]

  • 32. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement.
    Eriksson BI, Wille-Jørgensen P, Kälebo P, Mouret P, Rosencher N, Bösch P, Baur M, Ekman S, Bach D, Lindbratt S, Close P.
    N Engl J Med; 1997 Nov 06; 337(19):1329-35. PubMed ID: 9358126
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
    Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, Gent M, Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators.
    N Engl J Med; 2003 Jul 10; 349(2):146-53. PubMed ID: 12853587
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group.
    Br J Surg; 1997 Aug 10; 84(8):1099-103. PubMed ID: 9278651
    [Abstract] [Full Text] [Related]

  • 39. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF, Raskob GE, Davidson BL, Decousus H, Gallus A, Lensing AW, Piovella F, Prins MH, Büller HR.
    Thromb Haemost; 2009 Apr 10; 101(4):762-9. PubMed ID: 19350123
    [Abstract] [Full Text] [Related]

  • 40. Prophylaxis against venous thromboembolism after surgery for cancer.
    Moulias S, Bouchon JP, Meaume S.
    N Engl J Med; 2002 Jul 18; 347(3):220; author reply 220. PubMed ID: 12124417
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.